Myriad RBM: Q2 Solutions' Acquisition of Myriad RBM
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Myriad Genetics, Inc. on the deal. Myriad Genetics, Inc. (NASDAQ: MYGN), a genetic testing and precision medicine company, [...]
Read full article »
Myriad RBM is a Texas-based laboratory that provides solutions such as novel predictive, personalized and prognostic medicine testing.
Read more